Re: Timothée Olivier, Kerrington Powell, Vinay Prasad. Lutetium-177-PSMA-617 in Metastatic Castration-resistant Prostate Cancer: Limitations of the VISION Trial. Eur Urol. 2023;84:4-6

Eur Urol. 2023 Oct;84(4):e94-e95. doi: 10.1016/j.eururo.2023.04.043. Epub 2023 Jun 22.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Lutetium
  • Male
  • Prostate-Specific Antigen
  • Prostatic Neoplasms, Castration-Resistant* / drug therapy
  • Prostatic Neoplasms, Castration-Resistant* / pathology
  • Radioisotopes
  • Radiopharmaceuticals
  • Treatment Outcome

Substances

  • Lutetium-177
  • PSMA-617
  • Radioisotopes
  • Prostate-Specific Antigen
  • Lutetium
  • Radiopharmaceuticals